Next Article in Journal
Ethnomedicinal Uses of Plant Resources in the Machhapuchchhre Rural Municipality of Kaski District, Nepal
Previous Article in Journal
Clinical and Basic Studies on Therapeutic Efficacy of Herbal Medicines against Mycobacterial Infections
Previous Article in Special Issue
Screening of Crude Drugs Used in Japanese Kampo Formulas for Autophagy-Mediated Cell Survival of the Human Hepatocellular Carcinoma Cell Line
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Liquiritin and Liquiritigenin Induce Melanogenesis via Enhancement of p38 and PKA Signaling Pathways

1
Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo, Nagasaki 859-3298, Japan
2
Department of Health and Nutrition, Faculty of Health Management, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo, Nagasaki 859-3298, Japan
*
Author to whom correspondence should be addressed.
Medicines 2019, 6(2), 68; https://doi.org/10.3390/medicines6020068
Submission received: 21 May 2019 / Revised: 17 June 2019 / Accepted: 21 June 2019 / Published: 22 June 2019
(This article belongs to the Special Issue Plant-Derived Medicines and Biological Activity Evaluation)

Abstract

Background: Liquiritin (LQ) and its aglycone, liquiritigenin (LQG), are major flavonoids in licorice root (Glycyrrhiza spp.). Our preliminary screening identified LQ and LQG, which promote melanin synthesis in the melanoma cells. In this study, we investigated the molecular mechanism of melanin synthesis activated by LQ and LQG. Methods: Murine (B16-F1) and human (HMVII) melanoma cell lines were treated with LQ or LQG. After incubation, melanin contents, intracellular tyrosinase activity, and cell viability were evaluated. Protein levels were determined using Western blotting. Results: LQ and LQG activated melanin synthesis and intracellular tyrosinase activity. The induction of melanin and intracellular tyrosinase activity by LQG was higher than that by LQ. LQ and LQG induced the expression of tyrosinase, tyrosinase-related protein (TRP)-1, and TRP-2. LQ and LQG also enhanced microphthalmia-associated transcription factor (MITF) expression, and cyclic AMP-responsive element-binding protein (CREB) phosphorylation. The phosphorylation of p38 and extracellular signal-regulated kinase (ERK), but not Akt, was significantly increased by LQ or LQG. Furthermore, LQ- or LQG-mediated melanin synthesis was partially blocked by p38 inhibitor (SB203580) and protein kinase A (PKA) inhibitor (H-89); however, ERK kinase (MEK) inhibitor (U0126) and phosphatidylinositol-3-kinase (PI3K) inhibitor (LY294002) had no effect. Conclusions: The results suggest that LQ and LQG enhance melanin synthesis by upregulating the expression of melanogenic enzymes, which were activated by p38 and PKA signaling pathways, leading to MITF expression and CREB phosphorylation.
Keywords: licorice; liquiritigenin; liquiritin; melanin; tyrosinase; TRP-1/2; MITF; p38; PKA licorice; liquiritigenin; liquiritin; melanin; tyrosinase; TRP-1/2; MITF; p38; PKA

Share and Cite

MDPI and ACS Style

Uto, T.; Ohta, T.; Yamashita, A.; Fujii, S.; Shoyama, Y. Liquiritin and Liquiritigenin Induce Melanogenesis via Enhancement of p38 and PKA Signaling Pathways. Medicines 2019, 6, 68. https://doi.org/10.3390/medicines6020068

AMA Style

Uto T, Ohta T, Yamashita A, Fujii S, Shoyama Y. Liquiritin and Liquiritigenin Induce Melanogenesis via Enhancement of p38 and PKA Signaling Pathways. Medicines. 2019; 6(2):68. https://doi.org/10.3390/medicines6020068

Chicago/Turabian Style

Uto, Takuhiro, Tomoe Ohta, Akihisa Yamashita, Shunsuke Fujii, and Yukihiro Shoyama. 2019. "Liquiritin and Liquiritigenin Induce Melanogenesis via Enhancement of p38 and PKA Signaling Pathways" Medicines 6, no. 2: 68. https://doi.org/10.3390/medicines6020068

APA Style

Uto, T., Ohta, T., Yamashita, A., Fujii, S., & Shoyama, Y. (2019). Liquiritin and Liquiritigenin Induce Melanogenesis via Enhancement of p38 and PKA Signaling Pathways. Medicines, 6(2), 68. https://doi.org/10.3390/medicines6020068

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop